Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Overall these alterations in metabolism pathways resulted in a substantial reduction in the levels of metabolites such as aspartate, asparagine, glutamine, histidine, N-formimino-glutamate, sarcosine, and ethanolamine phosphate in LC patients ( Figure 4B , Supplementary Figure 3B )
bioRxiv 274 , 120087 (2022)
& Hashimoto, K
Researchers studying peptides for gut health often find that combining structural repair compounds with anti-inflammatory agents produces more complete results than either approach alone
It's worth noting that GLP-1 receptor agonists typically have a low risk of causing hypoglycaemia in adults when used alone, but any transfer to the infant could potentially influence blood sugar regulation in vulnerable newborns
Product Name: BPC-157 Classification: Gastric Pentadecapeptide Structural Description: 15-amino acid fragment of human gastric juice protein BPC (Body Protection Compound) CAS Number: 137525-51-0 Molecular Weight: 1419.53 g/mol Purity: 99% (verified by HPLC and Mass Spectrometry) Physical Form: Lyophilized (freeze-dried) powder Intended Use: In-vitro research use only not for human consumption Related research compounds Comparable catalog records with published variants and certificate status
US$ 27.41
US$ 23.95
US$ 21.82
US$ 21.02
US$ 25.38
US$ 29.47
US$ 23.60
US$ 28.61
